Marex Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$780K Buy
+2,001
New +$846K ﹤0.01% 562
2025
Q4
Sell
-1,000
Closed -$426K 1041
2025
Q3
$426K Hold
1,000
﹤0.01% 536
2025
Q2
$383K Sell
1,000
-17,399
-95% -$6.27M ﹤0.01% 410
2025
Q1
$6.36M Sell
18,399
-32,261
-64% -$10.4M 0.12% 93
2024
Q4
$15.2M Buy
50,660
+30,624
+153% +$10.7M 0.26% 64
2024
Q3
$8.14M Buy
+20,036
New +$7.34M 0.19% 73

Other funds holding HCA

Marex Group's HCA Position: Q2 2026 in Review

Marex Group opened a new position in HCA Healthcare (HCA) in Q2 2026: 2,001 shares worth $780K. The stake represents ﹤0.01% of the portfolio and ranks #562 among its holdings. This is a return to the name: Marex Group previously reported a position in HCA as recently as Q3 2025.

Marex Group first reported a position in HCA in Q3 2024 and has held it in 6 quarters since. The position peaked at $15.2M in Q4 2024. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Marex Group held 2,001 shares of HCA Healthcare worth $780K as of Q2 2026.
  • HCA Healthcare was a new Marex Group position in Q2 2026.
  • HCA Healthcare made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #562 holding.
  • Marex Group first reported a position in HCA Healthcare in Q3 2024 and has held it in 6 quarters since.
  • Marex Group's HCA Healthcare position peaked at $15.2M in Q4 2024.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.